Laboratory evaluation
| Variable | Normal value | Investigated patients3-150(n) | Mean (SD) | Abnormal values (n (%)) | Abnormal values (mean (range)) |
|---|---|---|---|---|---|
| Liver function variables | |||||
| Bilirubin direct (μmol/l) | < 7 | 28 | 3.7 (3.3) | 5 (18) | 9.2 (7.0 to 12.0) |
| Bilirubin total (μmol/l) | < 17 | 28 | 14.0 (8.7) | 9 (32) | 23.8 (18.0 to 39.0) |
| ALT (U/l) | < 37 | 28 | 31.8 (9.9) | 9 (32) | 42.9 (37.0 to 56.0) |
| AST (U/l) | < 47 | 28 | 33.5 (8.3) | 2 (7) | 50.5 (48.0 to 53.0) |
| AP (U/L) | Age related | 28 | 182.3 (111.5) | 6 21) | Age related |
| γGT (U/l) | < 56 | 28 | 64.4 (44.3) | 13 (46) | 99.3 (60.0 to 218.0) |
| Protein (g/l) | 60 to 80 | 26 | 72.2 (8.8) | 2 (8) | 47.0 (42.0 to 52.0) |
| Albumin (g/l) | > 35 | 24 | 47.1 (7.4) | 2 (8) | 24.4 (23.4 to 25.4) |
| Pseudocholinesterase (U/l) | 3200 to 7500 | 23 | 5665 (1540) | 1 (4) | 2633 |
| Haematological variables | |||||
| Haemoglobin (mmol/l) | 7.5 to 10.0 | 28 | 9.2 (1.0) | 7 (25) | 10.6 (10.0 to 11.4) |
| Haematocrit (l/l) | 0.37 to 0.45 | 25 | 0.43 (0.05) | 6 (24) | 0.50 (0.47 to 0.53) |
| Thrombocytes (109/l) | 150 to 350 | 27 | 205.5 (57.3) | 3 (11) | 119.3 (101.0 to 130.0) |
| Coagulation variables | |||||
| PT (s) | 10.0 to 12.9 | 24 | 14.1 (2.4) | 19 (79) | 14.6 (12.9 to 23.1) |
| APTT (s) | 20 to 29 | 24 | 28.1 (2.9) | 10 (42) | 30.9 (29.0 to 34.0) |
| Factor V (%) | 80 to 140 | 20 | 70.9 (16.1) | 16 (80) | 65.8 (27.0 to 79.0) |
| Factor VII (%) | 80 to 140 | 20 | 60.4 (20.4) | 17 (85) | 53.7 (22.0 to 75.0) |
| Antithrombin (%) | 80 to 140 | 24 | 103.4 (11.2) | 0 (0) | – |
| Plasminogen (%) | 80 to 140 | 22 | 82.1 (13.2) | 11 (50) | 71.9 (63.0 to 79.0) |
| Protein C activity (%) | Age related | 21 | 80.8 (24.2) | 5 (24) | Age related |
| Protein S, total (%) | 65 to 108 | 21 | 90.1 (13.5) | 0 (0) | – |
| Protein S, free (%) | 26 to 61 | 21 | 47.5 (9.3) | 0 (0) | – |
| d-dimer (μg/l) | < 400 | 19 | 298 (241) | 4 (21) | 688.8 (412.0 to 990.0) |
| TAT (μg/l) | < 4.6 | 16 | 3.0 (1.9) | 3 (19) | 6.5 (5.2 to 7.2) |
↵3-150 Not all measurements were available in for patients.
ALT, alanine aminotransferase; AP, alkaline phosphatase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; γGT, γ-glutamyltranspeptidase; PT, partial thromboplastin time; TAT, thrombin-antithrombin complex.